ROC analysis of MIC-1 and CA19-9.

Slides:

Advertisements

Similar presentations

The expression and signaling of FGFR3 in WM cells.

Advertisements

Additional file 2: Figure S1

Zhi-hui Hou et al. JIMG 2012;5:

Rearrangements of Gene A and Gene B

Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.

Heiko Lehrmann et al. JACEP 2018;j.jacep

Figure 2. ROC curves for different group comparisons

ROC for predicted combined death or neurodevelopmental impairment compared with actual death or neurodevelopmental impairment as stratified by gestational.

Epitope Mapping Performance using a single peptide microarray.

Serum LAMC2 levels in pancreatic adenocarcinoma (PDAC) and other samples from Japan. Serum LAMC2 levels in pancreatic adenocarcinoma (PDAC) and other samples.

ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.

Christopher T. Nguyen et al. BTS 2018;3:97-109

Comparative receiver operating characteristic (ROC) curves and the area under the curve (AUC) in association with 30-day mortality for severity scores.

Receiver operating characteristic curves (ROC) for the metabolites between the systemic inflammatory response syndrome (n=15) and sepsis (n=35) groups.

Receiver operating characteristic (ROC) curves (area under the curve (AUC) (95% CI)) for FACED (forced expiratory volume in 1 s, age, chronic colonisation.

—ROC curves for each simple test compared with NCS (gold standard) plotting the sensitivity versus 1-specificity (the false-positive rate) for different.

Fig. 3 ROC curves of mCCNA1 and mVIM assayed in esophageal cytology brushings from control normal-appearing GE junctions versus BE and EAC cases. ROC curves.

A, IC50 dose–response curves of SYD985, T-DM1, and ADC isotype control in all USC cell lines tested in vitro (i.e., HER2 3+ cell lines, P =

Receiver-operating characteristic curves showing the performance of the diabetes risk score in predicting diabetes in the United Arab Emirates (UAE) citizens.

ROC curves showing additive value of DHE in diagnosing ongoing episode of recurrence among all patients with established history of recurrent pericarditis.

In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s

A, Top inhibitors of Ba/F3 transformed with CD74–ROS1, color coded by clinical development status: FDA-approved (green), phase III (yellow), phase II (blue),

G3139 substitutes for heparin, which is required for the biological activity of FGF2. G3139 substitutes for heparin, which is required for the biological.

Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.

A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.

Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+

Comparison of MGM-FCI-MAX-derived with retrained lung cancer prediction models on the training cohort. Comparison of MGM-FCI-MAX-derived with retrained.

Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.

Radiosensitization by combined Wee1 and PARP inhibition.

A, scatterplots of qMSP analysis of candidate genes promoters in the prevalence screen cohort, which consisted of 55 HNSCC tumor tissue samples and 37.

Binding and internalization of bispecific immunotoxins.

Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3

Pre- and post-vorinostat values of ER-related gene expression using the Oncotype DX 21-gene assay. Pre- and post-vorinostat values of ER-related gene expression.

A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.

Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases. Pancreatic cancer cell lines are sensitive to knockdown of outlier kinases.

Identification of molecular subtypes of leiomyosarcoma (LMS) in the TCGA data. Identification of molecular subtypes of leiomyosarcoma (LMS) in the TCGA.

Peptide dose-response curves were done to estimate the avidity of these HTL for peptide TARP1-14 (A) and TARP14-27 (B-E) using autologous PBMCs and dendritic.

FILM immunohistochemical protein signature is significantly associated with poor survival. FILM immunohistochemical protein signature is significantly.

FILM protein signature predicts poor survival in nontreated stage-IB lung adenocarcinoma. FILM protein signature predicts poor survival in nontreated stage-IB.

A, unsupervised clustering of all BRCA1 (red), BRCA2 (blue), and sporadic (green) breast tumors of our collection using the regions reported as discriminative.

Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.

Receiver operating characteristic (ROC) curves assessing pre-trilostane, three-hour post-trilostane and post-adrenocorticotrophic hormone (ACTH) cortisol.

Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.

Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.

Reduced klotho expression in pancreatic cancer.

Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.

Tivantinib behaves as an antimitotic agent.

Kaplan–Meier curves for RFS and OS by various marker groups.

Mean weight change from original weight of (a) BALB/c (b) DBA/2 mice after one (♦) or two (▴) injections of 10 mg/kg and one (▪) or two (×) injections.

Competition by G3139 for binding of ClRNH32P-OdT18 to collagen I (A), FGF2 (B), PDGF BB (C), and VEGF (D). Competition by G3139 for binding of ClRNH32P-OdT18.

Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.

A, pretreatment CT scan of pelvic lymphadenopathy (identified by white arrow) in 1 patient with documented response to 1α-OH-D2. A, pretreatment CT scan.

CD24 expression. CD24 expression. A, By global gene expression, CD24 is found to be highly upregulated in SEF (80×) and in LGFMS (37×) as compared with.

Mean percentage change from baseline in total IGF-I and the R1507 serum concentration values following a single i.v. administration of R mg/kg (n.

Immunoblot analysis in PANC1 and MSTO-211H cells.

DFS and DSS curves according to low, intermediate, and high stromal CD8+ T-cell density in the four different cohorts; A and B, University Hospital of.

A summary of the average level of methylation of selected MCA/RDA MICPs by bisulfite-modified genomic sequencing. A summary of the average level of methylation.

A, antitumor activity of temozolomide (30 mg/kg for 5 days), talazoparib (0.25 mg/kg twice daily for 5 days), or in combination against “sensitive” Ewing.

Survival RR enhancement according to the specific protocol in treated mice. Survival RR enhancement according to the specific protocol in treated mice.

Biopsies of the vaccination site were obtained 48 h after the first vaccination. Biopsies of the vaccination site were obtained 48 h after the first vaccination.

Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.

CPGL is a growth suppressor in pancreatic cancer cell lines.

Cells expressing mutant NADK-I90F exhibit low ROS and elevated NADP and NADPH levels. Cells expressing mutant NADK-I90F exhibit low ROS and elevated NADP.

Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.

A, Changes in BRAFV600E cfDNA allele fraction from baseline after one dose of treatment for 12 patients with serial samples available, classified according.

Phenotypic diversity of less predominant B-lineage clones.

Receiver operating characteristic (ROC) curves for discriminating diabetic subjects without retinopathy from control subjects using a logistic regression.

Receiver operator characteristic (ROC) curve for fasting blood glucose (FBG) predicting posttransplantation diabetes (PTD) using time 0 FBG (a) and screening.

Relative risks are plotted at the midpoints of the three time periods.

Receiver operating characteristic (ROC) curves for Saint George’s Respiratory Questionnaire (SGRQ) category scores predicting chronic obstructive pulmonary.

Presentation transcript:

ROC analysis of MIC-1 and CA19-9. ROC analysis of MIC-1 and CA19-9. Left ROC curve, pancreatic cancer versus normal controls: black, CA19-9 (AUC, 0.78); blue, MIC-1 (AUC, 0.99); red, combination (AUC, 0.99). Central curve, pancreatic cancer versus chronic pancreatitis: black, CA19-9 (AUC, 0.74); blue, MIC-1 (AUC, 0.81); red, combination (AUC, 0.84). Right curve, pancreatic cancer versus noncancer: black, CA19-9 (AUC, 0.76); blue, MIC-1 (AUC, 0.90); red, combination (AUC, 0.91). Jens Koopmann et al. Clin Cancer Res 2006;12:442-446 ©2006 by American Association for Cancer Research